8-K: Acuren Corporation Reports Improved Year-Over-Year Results and Announces Planned NYSE Listing

Acuren Corporation announced improved financial results for the third quarter and nine-month periods ended September 30, 2024, and plans to list on the NYSE in early 2025.

Summary

• Acuren Corporation has released its financial results for the third quarter and nine months ending September 30, 2024.
• The company's results were impacted by the acquisition of ASP Acuren Holdings, Inc.
• For the third quarter, combined revenue reached $303.0 million, a 14.1% increase compared to the prior year predecessor period.
• Combined adjusted gross profit for the third quarter was $89.8 million, or 29.6% of revenue, compared to 29.3% in the prior period.
• Combined adjusted EBITDA for the third quarter was $51.3 million, a 14.8% increase from the prior period, with a margin of 16.9%.
• For the nine-month period, combined revenue was $835.4 million, a 7.1% increase from the prior year predecessor period.
• Combined adjusted gross profit for the nine-month period was $244.8 million, or 29.3% of revenue, compared to 28.4% in the prior period.
• Combined adjusted EBITDA for the nine-month period was $145.9 million, a 15.2% increase from the prior period, with a margin of 17.5%.
• The company completed the ASP Acuren Acquisition on July 30, 2024, for $1.88 billion.
• Acuren anticipates its common stock will begin trading on the OTC Market before the end of the year and plans to list on the NYSE in the first quarter of 2025.
• The company has over $130 million in cash on hand.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook with strong revenue and EBITDA growth, and a planned NYSE listing. However, the significant net loss and the complexities of the acquisition temper the overall sentiment.

Positives

• Acuren demonstrated strong year-over-year growth in revenue and adjusted EBITDA.
• The company's margins have improved, indicating better operational efficiency.
• The successful acquisition of ASP Acuren is expected to contribute to future growth.
• The planned listing on the NYSE is a positive step for the company's visibility and access to capital.
• Acuren has a solid cash position, providing financial flexibility.

Negatives

• The company reported a significant net loss of $89.8 million for the Successor period in both the third quarter and nine-month results.
• The company's income from operations was a loss of $79.2 million for the Successor period in both the third quarter and nine-month results.
• The comparability of results is impacted by the ASP Acuren acquisition, making it difficult to assess underlying performance.

Risks

• The company's future performance is subject to risks and uncertainties, as detailed in their SEC filings.
• The integration of ASP Acuren may present challenges.
• The company's planned listing on the NYSE is subject to market conditions and regulatory approvals.
• The company's financial results are presented using non-GAAP measures, which may not be directly comparable to other companies.

Future Outlook

Acuren expects to begin trading on the OTC Market before the end of 2024 and plans to list on the NYSE during the first quarter of 2025. The company believes its strong balance sheet, EBITDA growth, and operational excellence will deliver long-term value to shareholders.

Management Comments

• Tal Pizzey, CEO of Acuren, stated that the strong year-to-date results reflect continued improvement in service revenue and margins, driven by increased demand, new sales, and pricing initiatives.
• Robert A.E. Franklin, Co-Chairman of Acuren, commented that the company expects to begin trading on OTC imminently and looks forward to an NYSE debut in the new year.

Industry Context

Acuren operates in the Testing, Inspection, and Certification (TIC) industry, which is driven by recurring maintenance needs and compliance mandates. The company's focus on asset integrity services positions it well within this sector, and the planned NYSE listing could enhance its competitive standing.

Comparison to Industry Standards

• While specific competitor data is not provided in the document, Acuren's adjusted EBITDA margin of 16.9% for the third quarter and 17.5% for the nine-month period suggests a strong performance within the TIC industry.
• Companies like Intertek, SGS, and Bureau Veritas are major players in the TIC sector, and Acuren's growth and planned NYSE listing indicate its ambition to compete at a similar level.
• The acquisition of ASP Acuren is a significant move that could position Acuren to better compete with these larger players by expanding its service offerings and market reach.

Stakeholder Impact

• Shareholders can expect potential long-term value from the company's growth and planned NYSE listing.
• Employees may benefit from the company's expansion and improved financial performance.
• Customers can expect continued service quality and potentially expanded offerings.
• Suppliers and creditors may see increased business opportunities with the company's growth.

Next Steps

• The company anticipates its common stock will begin trading on the OTC Market prior to the end of the year.
• The company intends to apply to list its common stock on the New York Stock Exchange during the first quarter of 2025.

Key Dates

Keywords

Acuren, ASP Acuren, financial results, EBITDA, revenue, NYSE, OTC, acquisition, asset integrity, testing, inspection, certification